ALB and pancreatic neoplasm: In addition to the above-mentioned Doxil, Abraxane (Celgene, Summit, NJ) is another nanotechnology-based chemotherapeutic agent for malignant tumors, which is a nanoparticle albumin-bound paclitaxel approved for breast cancer, non-small cell lung cancer, and pancreatic cancer by the FDA and for gastric cancer in Japan19,20.